Tempus Announces Initial Results from its Multimodal Foundation Model Efforts for Novel and Scalable Insight Generation in Oncology
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the latest results from its mission to build Multimodal Foundation Models at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. Tempus has been building novel biological foundation models and agentic workflows by leveraging its more than 500 petabytes of rich, molecularly grounded data—more than 45 million total de-identified patient journeys, 1.5
Why this byte is shareable
Signal quality
observed
Confidence badge and source context included.
Entity anchor
AI News
Clear company or model context for distribution.
Export ready
1200 x 630 card
Optimized for X, LinkedIn, and chat previews.
Why it matters
AI News can change capability, routing, cost, or product scope for builders shipping against current model APIs.
Suggested launch post
Use this in X threads, community posts, internal team chats, or launch recaps.
Tempus Announces Initial Results from its Multimodal Foundation Model Efforts for Novel and Scalable Insight Generation in Oncology Why it matters: AI News can change capability, routing, cost, or product scope for builders shipping against current model APIs. Source: Financ...
Permalink: https://a2zai.ai/bytes/tempus-announces-initial-results-from-its-multimodal-foundation-model-efforts-fo-31484e61
Social card: https://a2zai.ai/bytes/tempus-announces-initial-results-from-its-multimodal-foundation-model-efforts-fo-31484e61/opengraph-image